1. Home
  2. SGMO vs PHD Comparison

SGMO vs PHD Comparison

Compare SGMO & PHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMO
  • PHD
  • Stock Information
  • Founded
  • SGMO 1995
  • PHD 2004
  • Country
  • SGMO United States
  • PHD United States
  • Employees
  • SGMO N/A
  • PHD N/A
  • Industry
  • SGMO Biotechnology: Biological Products (No Diagnostic Substances)
  • PHD Investment Managers
  • Sector
  • SGMO Health Care
  • PHD Finance
  • Exchange
  • SGMO Nasdaq
  • PHD Nasdaq
  • Market Cap
  • SGMO 122.8M
  • PHD 122.6M
  • IPO Year
  • SGMO 2000
  • PHD N/A
  • Fundamental
  • Price
  • SGMO $0.51
  • PHD $9.95
  • Analyst Decision
  • SGMO Strong Buy
  • PHD
  • Analyst Count
  • SGMO 7
  • PHD 0
  • Target Price
  • SGMO $5.29
  • PHD N/A
  • AVG Volume (30 Days)
  • SGMO 5.2M
  • PHD 67.7K
  • Earning Date
  • SGMO 08-07-2025
  • PHD 01-01-0001
  • Dividend Yield
  • SGMO N/A
  • PHD 11.43%
  • EPS Growth
  • SGMO N/A
  • PHD N/A
  • EPS
  • SGMO N/A
  • PHD 1.27
  • Revenue
  • SGMO $81,706,000.00
  • PHD N/A
  • Revenue This Year
  • SGMO $21.24
  • PHD N/A
  • Revenue Next Year
  • SGMO N/A
  • PHD N/A
  • P/E Ratio
  • SGMO N/A
  • PHD $7.60
  • Revenue Growth
  • SGMO 565.52
  • PHD N/A
  • 52 Week Low
  • SGMO $0.41
  • PHD $8.30
  • 52 Week High
  • SGMO $3.18
  • PHD $9.81
  • Technical
  • Relative Strength Index (RSI)
  • SGMO 44.92
  • PHD 58.09
  • Support Level
  • SGMO $0.47
  • PHD $9.86
  • Resistance Level
  • SGMO $0.56
  • PHD $9.97
  • Average True Range (ATR)
  • SGMO 0.03
  • PHD 0.05
  • MACD
  • SGMO -0.00
  • PHD -0.00
  • Stochastic Oscillator
  • SGMO 32.31
  • PHD 64.29

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

About PHD Pioneer Floating Rate Fund Inc.

Pioneer Floating Rate Trust is a diversified, closed-end fund. It invests in the fixed income markets of the United States. The fund basically invests in senior secured floating-rate loans. It benchmarks the performance of its portfolio against the other High Yield Loans Index banks.

Share on Social Networks: